Treatment for S. aureus skin infection works in mouse model
Por um escritor misterioso
Descrição
Scientists from the National Institutes of Health and University of Chicago have found a promising treatment method that in laboratory mice reduces the severity of skin and soft-tissue damage caused by USA300, the leading cause of community-associated Staphylococcus aureus infections in the United States.
Linker-Improved Chimeric Endolysin Selectively Kills
Infection with Persister Forms of Staphylococcus aureus Causes a
Toxin expression during Staphylococcus aureus infection imprints
Broad and Effective Protection against Staphylococcus aureus Is
Mouse model of hematogenous implant-related Staphylococcus aureus
Chronic Staphylococcus aureus infection is cured by theory-driven
Cyclic-di-GMP stimulates keratinocyte innate immune responses and
Feline Antimicrobial Bacterium May Help Fight Difficult-to-Treat
Complestatin and corbomycin are effective in a mouse skin
An optimized mouse model of Staphylococcus aureus infected
Superantigens promote Staphylococcus aureus bloodstream infection
de
por adulto (o preço varia de acordo com o tamanho do grupo)